NEW YORK (Reuters Health) – The benefits of preemptive percutaneous mitral commissurotomy (PMC) in asymptomatic patients with moderate mitral stenosis appear to outweigh the inherent risks of the…
NEW YORK (Reuters Health) – For prevention of contrast-induced nephropathy (CIN), volume supplementation with sodium chloride 0.9% for 24 hours was more effective than a 7-hour regimen of…
NEW YORK (Reuters Health) – A proximal balloon occlusion device provided better protection against cerebral emboli than a filter device during coronary artery stenting (CAS) in the first…
NEW YORK (Reuters Health) – Three cardiologists from China say intracoronary administration of a glycoprotein IIb/IIIa receptor inhibitor (GPI) “can be recommended as a preferred regimen” during primary…
NEW YORK (Reuters Health) – Preemptive ibuprofen treatment reduces the need for additional pain relief during medically induced abortion, without affecting success rates, an Israeli group reports in…
NEW YORK (Reuters Health) – About one in four patients with peripheral T-cell lymphoma (PTCL) who do not respond to or relapse after systemic therapy are likely to…
NEW YORK (Reuters Health) – The effectiveness of gastric variceal obturation for controlling gastric variceal bleeding is not improved with the addition of non-selective beta-blocker therapy, a Taiwanese…
NEW YORK (Reuters Health) – Women with early-stage estrogen receptor-positive breast cancer fare somewhat better with 2 years of tamoxifen followed by 3 years of anastrozole than with…
NEW YORK (Reuters Health) – Untreated gastroesophageal reflux does not appear to be a factor in poorly controlled asthma in children, as adding a proton pump inhibitor to…
NEW YORK (Reuters Health) – Patients with a recent non-cardioembolic ischemic stroke who are found to have a silent brain infarction (SBI) on MRI are not at significantly…
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of…
NEW YORK (Reuters Health) – Hyperprolactinemia is a relatively common cause of secondary amenorrhea in young women with menstruation irregularities, Korean researchers report in a December 19th on-line…
